Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEPPER: Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704Phase 4Completed
- Sponsor
- Dartmouth Health
- Start
- Dec 2016
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of aspirin, warfarin, rivaroxaban in pulmonary embolism (PE), venous thrombosis, sponsored by Dartmouth Health. Started Dec 2016; status: completed.
02
Drugs
aspirinwarfarinrivaroxaban
03
Conditions
pulmonary embolism (PE)venous thrombosis
Beyond the preview
Go deeper on NCT02810704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810704.